BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27890521)

  • 1. Financial incentives for diabetes prevention in a Medicaid population: Study design and baseline characteristics.
    Desai J; Taylor G; Vazquez-Benitez G; Vine S; Anderson J; Garrett JE; Gilmer T; Vue-Her H; Schiff J; Rinn S; Engel K; Michael A; O'Connor PJ
    Contemp Clin Trials; 2017 Feb; 53():1-10. PubMed ID: 27890521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the We Can Prevent Diabetes cluster-randomized controlled trial.
    Desai JR; Vazquez-Benitez G; Taylor G; Johnson S; Anderson J; Garrett JE; Gilmer T; Vue-Her H; Rinn S; Engel K; Schiff J; O'Connor PJ
    BMC Public Health; 2020 Oct; 20(1):1587. PubMed ID: 33087083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of financial incentives on utilization and outcomes of diabetes prevention programs among Medicaid managed care adults in New York state.
    Chin JY; Matson J; McCauley S; Anarella J; Gesten F; Roohan P
    Contemp Clin Trials; 2020 Apr; 91():105960. PubMed ID: 32087338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Process- and Outcome-Based Financial Incentives on Weight Loss Among Prediabetic New York Medicaid Patients: A Randomized Clinical Trial.
    VanEpps EM; Troxel AB; Villamil E; Saulsgiver KA; Zhu J; Chin JY; Matson J; Anarella J; Roohan P; Gesten F; Volpp KG
    Am J Health Promot; 2019 Mar; 33(3):372-380. PubMed ID: 30021451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Moin T; Duru OK; Turk N; Chon JS; Frosch DL; Martin JM; Jeffers KS; Castellon-Lopez Y; Tseng CH; Norris K; Mangione CM
    J Gen Intern Med; 2019 Nov; 34(11):2652-2659. PubMed ID: 31471729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Prevention Program Translation in the Veterans Health Administration.
    Moin T; Damschroder LJ; AuYoung M; Maciejewski ML; Datta SK; Weinreb JE; Steinle NI; Billington C; Hughes M; Makki F; Holleman RG; Kim HM; Jeffreys AS; Kinsinger LS; Burns JA; Richardson CR
    Am J Prev Med; 2017 Jul; 53(1):70-77. PubMed ID: 28094135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial.
    Toro-Ramos T; Michaelides A; Anton M; Karim Z; Kang-Oh L; Argyrou C; Loukaidou E; Charitou MM; Sze W; Miller JD
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17842. PubMed ID: 32459631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results From a Trial of an Online Diabetes Prevention Program Intervention.
    Moin T; Damschroder LJ; AuYoung M; Maciejewski ML; Havens K; Ertl K; Vasti E; Weinreb JE; Steinle NI; Billington CJ; Hughes M; Makki F; Youles B; Holleman RG; Kim HM; Kinsinger LS; Richardson CR
    Am J Prev Med; 2018 Nov; 55(5):583-591. PubMed ID: 30262149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial.
    Yeung KF; Gandhi M; Lam AYR; Julianty S; Chia AYM; Tan GCS; Goh SY; Ho ETL; Koh AFY; Tan GSW; Shum EJW; Finkelstein EA; Jafar TH; Teoh YL; van Dam RM; Whitton C; Thumboo J; Bee YM
    Trials; 2021 Aug; 22(1):522. PubMed ID: 34362409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries.
    Gilmer T; O'Connor PJ; Schiff JS; Taylor G; Vazquez-Benitez G; Garrett JE; Vue-Her H; Rinn S; Anderson J; Desai J
    Health Serv Res; 2018 Dec; 53(6):4704-4724. PubMed ID: 29770445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a comparative effectiveness trial to prevent type 2 diabetes in mothers and children: the ENCOURAGE healthy families study.
    Hannon TS; Carroll AE; Palmer KN; Saha C; Childers WK; Marrero DG
    Contemp Clin Trials; 2015 Jan; 40():105-11. PubMed ID: 25457793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial.
    Kullgren JT; Youles B; Shetty S; Richardson C; Fagerlin A; Heisler M
    Trials; 2017 Apr; 18(1):167. PubMed ID: 28388933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the YMCA Diabetes Prevention Program throughout an Integrated Health System: A Translational Study.
    Adams R; Hebert CJ; Mcvey L; Williams R
    Perm J; 2016; 20(4):15-241. PubMed ID: 27828773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of A 12-Month Intensive Lifestyle Monitoring Program in Predominantly Overweight/Obese Arab Adults with Prediabetes.
    Wani K; Alfawaz H; Alnaami AM; Sabico S; Khattak MNK; Al-Attas O; Alokail MS; Alharbi M; Chrousos G; Kumar S; Al-Daghri NM
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32059477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA).
    Damschroder LJ; Reardon CM; AuYoung M; Moin T; Datta SK; Sparks JB; Maciejewski ML; Steinle NI; Weinreb JE; Hughes M; Pinault LF; Xiang XM; Billington C; Richardson CR
    Implement Sci; 2017 Jul; 12(1):94. PubMed ID: 28747191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program.
    Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project.
    Katula JA; Vitolins MZ; Rosenberger EL; Blackwell CS; Morgan TM; Lawlor MS; Goff DC
    Diabetes Care; 2011 Jul; 34(7):1451-7. PubMed ID: 21593290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Financial Incentives on Diabetes Prevention Class Attendance and Program Completion: Evidence From Minnesota, Montana, and New York.
    Alva ML; Romaire M; Acquah J
    Am J Health Promot; 2019 May; 33(4):601-605. PubMed ID: 30122055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of artificial intelligence vs. human coaching in diabetes prevention: a study protocol for a randomized controlled trial.
    Abusamaan MS; Ballreich J; Dobs A; Kane B; Maruthur N; McGready J; Riekert K; Wanigatunga AA; Alderfer M; Alver D; Lalani B; Ringham B; Vandi F; Zade D; Mathioudakis NN
    Trials; 2024 May; 25(1):325. PubMed ID: 38755706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.